Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    We Ask Analysts How Will Pharma and Medtech Companies Spend Billions in Repatriated OUS Profits?

    We Ask Analysts How Will Pharma and Medtech Companies Spend Billions in Repatriated OUS Profits?

    FromOIS Podcast | Ophthalmology's leading Podcast

    Start listeningView podcast show

    We Ask Analysts How Will Pharma and Medtech Companies Spend Billions in Repatriated OUS Profits?

    FromOIS Podcast | Ophthalmology's leading Podcast

    ratings:
    Length:
    29 minutes
    Released:
    Jan 25, 2018
    Format:
    Podcast episode

    Description

    Apple made headlines with a promise to spend repatriated dollars on R&D in the US. In this week’s podcast we talk with three Wall Street analysts to understand what we can expect to see from pharma and Medtech companies following the monster acquisitions of Juno, Kite et al. What ophthalmology companies might be acquisition targets? Will Medtech companies follow suit?
    Released:
    Jan 25, 2018
    Format:
    Podcast episode

    Titles in the series (100)

    Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.